BNTC
Benitec Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.36
+3.08%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-25.7%
Return on equity
-24.9%
Return on assets
-28.8%
Return on invested capital
0.00x
Asset turnover
-$17.0M
Cash from operations
$5.16
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026